SomnoMed Limited

SOM

AU000000SOM1

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 01:59:07 2024-04-18 am EDT			5-day change	1st Jan Change
0.205 ^AUD	-4.65%		-2.38%	-59.00%

Apr. 10	Somnomed Raises AU$5.8 Million in Institutional Entitlement Offer; AU$16.8 Million Retail Component to Launch April 16	MT
Apr. 09	SomnoMed Lowers Earnings, Revenue Guidance for Fiscal 2024; to Launch AU$22.6 Million Entitlement Offer	MT

SomnoMed Limited Reports Unaudited Revenue Results for the First Quarter of 2021

October 20, 2020 at 06:22 pm EDT

SomnoMed Limited reported unaudited revenue results for the first quarter of 2021. For the quarter, the company reported total revenue of AUD 13,725,000.

Latest news about SomnoMed Limited

Somnomed Raises AU$5.8 Million in Institutional Entitlement Offer; AU$16.8 Million Retail Component to Launch April 16	Apr. 09	MT
SomnoMed Lowers Earnings, Revenue Guidance for Fiscal 2024; to Launch AU$22.6 Million Entitlement Offer	Apr. 09	MT
Somnomed Requests Voluntary Share Suspension Continuation	Apr. 04	MT
Wilsons Downgrades Somnomed to Marketweight From Overweight; Price Target is AU$0.45	Mar. 13	MT
SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
SomnoMed Appoints Co-CEOs	Feb. 22	MT
SomnoMed Grows Fiscal Q1 Revenue	23-10-30	MT
SomnoMed Limited Announces Resignation of Hilton Brett as Non-Executive Director	23-10-11	CI
Transcript : SomnoMed Limited, 2023 Earnings Call, Aug 31, 2023	23-08-31
SomnoMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Somnomed Limited Announces Executive Changes	23-07-05	CI
SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
SomnoMed Limited Reaffirms Earnings Guidance for the Year 2023	22-10-28	CI
Transcript : SomnoMed Limited, 2022 Earnings Call, Aug 23, 2022	22-08-22
Somnomed Fiscal Q4 Revenue Rises 32%	22-07-26	MT
Transcript : SomnoMed Limited, H1 2022 Earnings Call, Feb 22, 2022	22-02-21
SomnoMed Introduces Rest Assure	22-02-21	CI
SomnoMed Limited Provides Earnings Guidance for the Second Half of Fiscal Year 2022 and Reaffirms Earnings Guidance for the Fiscal Year 2022	22-02-21	CI
SomnoMed Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-21	CI
SomnoMed Develops Technology-Enabled Oral Appliance	22-01-30	MT
SomnoMed Limited Announces World First Technology Enabled Oral Appliance	22-01-30	CI
Transcript : SomnoMed Limited - Shareholder/Analyst Call	21-11-24
SomnoMed : Fiscal Q1 Revenue Rises 14%; Shares Climb 6%	21-10-25	MT
ADDvantage Technologies : Names Michael Rutledge Finance Chief	21-09-03	MT
Transcript : SomnoMed Limited, 2021 Earnings Call, Aug 24, 2021	21-08-23

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Companyâs segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Ratings for SomnoMed Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.215 AUD

Average target price

1.26 AUD

Spread / Average Target

+486.05%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SOMNOMED LIMITED	-59.00%	18.78M
ABBOTT LABORATORIES	-3.79%	184B
MEDTRONIC PLC	-4.01%	105B
BECTON, DICKINSON AND COMPANY	-4.77%	67.09B
DEXCOM, INC.	+7.87%	51.61B
CENCORA, INC.	+16.18%	47.55B
HOYA CORPORATION	+0.60%	39.95B
WEST PHARMACEUTICAL SERVICES, INC.	+7.17%	27.62B
SARTORIUS STEDIM BIOTECH	-15.53%	25.74B
METTLER-TOLEDO INTERNATIONAL, INC.	-1.23%	25.62B

Other Medical Equipment, Supplies & Distribution